Cargando…

Dependence receptors: new targets for cancer therapy

Dependence receptors are known to promote survival and positive signaling such as proliferation, migration, and differentiation when activated, but to actively trigger apoptosis when unbound to their ligand. Their abnormal regulation was shown to be an important feature of tumorigenesis, allowing ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brisset, Morgan, Grandin, Mélodie, Bernet, Agnès, Mehlen, Patrick, Hollande, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573599/ https://www.ncbi.nlm.nih.gov/pubmed/34542930 http://dx.doi.org/10.15252/emmm.202114495

Ejemplares similares

Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity
por: Brisset, Morgan, et al.
Publicado: (2023)

Inhibition of DNA methylation promotes breast tumor sensitivity to netrin‐1 interference
por: Grandin, Mélodie, et al.
Publicado: (2016)

Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers
por: Mehlen, P, et al.
Publicado: (2005)

Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
por: Shembrey, Carolyn, et al.
Publicado: (2022)

Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells
por: Devailly, Guillaume, et al.
Publicado: (2015)

Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention
por: Chang, Aeson, et al.
Publicado: (2015)

Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response
por: Shembrey, Carolyn, et al.
Publicado: (2019)

A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients
por: Shembrey, Carolyn, et al.
Publicado: (2023)

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4
por: Royet, Amélie, et al.
Publicado: (2017)

Breast cancer: Muscarinic receptors as new targets for tumor therapy
por: Español, Alejandro, et al.
Publicado: (2021)

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
por: Sun, Hongguang, et al.
Publicado: (2014)

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
por: Ceder, Sophia, et al.
Publicado: (2020)

Death receptors as targets for anti-cancer therapy
por: Papenfuss, Kerstin, et al.
Publicado: (2008)

Eph receptors and ephrins as targets for cancer therapy
por: Xi, Hong-Qing, et al.
Publicado: (2012)

Receptor Tyrosine Kinase-Targeted Cancer Therapy
por: Yamaoka, Toshimitsu, et al.
Publicado: (2018)

DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment
por: Mathot, P, et al.
Publicado: (2017)

Sonic Hedgehog Promotes Tumor Cell Survival by Inhibiting CDON Pro-Apoptotic Activity
por: Delloye-Bourgeois, Céline, et al.
Publicado: (2013)

Floor plate-derived netrin-1 is dispensable for commissural axon guidance
por: Dominici, Chloé, et al.
Publicado: (2017)

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)

Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death
por: Paradisi, Andrea, et al.
Publicado: (2013)

The Insulin Receptor: A New Target for Cancer Therapy
por: Malaguarnera, Roberta, et al.
Publicado: (2011)

The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
por: Wang, Tao, et al.
Publicado: (2023)

Peptide functionalized liposomes for receptor targeted cancer therapy
por: Aronson, Matthew R., et al.
Publicado: (2021)

CD155 and Its Receptors as Targets for Cancer Therapy
por: Paolini, Rossella, et al.
Publicado: (2023)

Targeting the EGF Receptor for Ovarian Cancer Therapy
por: Zeineldin, Reema, et al.
Publicado: (2010)

Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015)

Neuropilins: A New Target for Cancer Therapy
por: Grandclement, Camille, et al.
Publicado: (2011)

New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015)

Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
por: Simon, Nathan, et al.
Publicado: (2016)

New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells
por: Liu, Yanni, et al.
Publicado: (2022)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

Welfare Problems in Cattle, Pigs, and Sheep that Persist Even Though Scientific Research Clearly Shows How to Prevent Them
por: Grandin, Temple
Publicado: (2018)

Evaluation of the welfare of cattle housed in outdoor feedlot pens
por: Grandin, Temple
Publicado: (2016)

XPO1-dependent nuclear export as a target for cancer therapy
por: Azizian, Nancy G., et al.
Publicado: (2020)

Changing the History of Prostate Cancer with New Targeted Therapies
por: Hernando Polo, Susana, et al.
Publicado: (2021)

New targets for therapy in breast cancer: Farnesyltransferase inhibitors
por: Head, Julia, et al.
Publicado: (2004)

New and Emerging Targeted Therapies for Advanced Breast Cancer
por: Lau, Kristie H., et al.
Publicado: (2022)

New developments in targeted therapy for metastatic colorectal cancer
por: Wong, Ambrose H. N., et al.
Publicado: (2023)

Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
por: Crona, Daniel J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bucga5pal54l1kffimrr38dc4s